Resultados de procura - P Rhodes
- Mostrando 1 - 16 Resultados de 16
-
1
-
2
Practical syntactic error recovery por Susan L. Graham, Steven P. Rhodes
Publicado 1975Artigo -
3
-
4
-
5
-
6
Annals of Internal Medicine por R. T. Senie, Paul Peter Rosen, P. Rhodes, M. L. Lesser, D. W. Kinne
Publicado 1992Artigo -
7
-
8
-
9
-
10
Targeted Lipidomics in Drosophila melanogaster Identifies Novel 2-Monoacylglycerols and N-acyl Amides por Giuseppe Tortoriello, Brandon P. Rhodes, Sara M. Takacs, Jordyn Stuart, А. Баснет, Siham Raboune, Theodore S. Widlanski, Patrick Doherty, Tibor Harkany, Heather B. Bradshaw
Publicado 2013Artigo -
11
A link between catalytic activity, IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2. por Thomas Dudler, Denise Cantarelli Machado, Ludger Kolbe, R. R. Annand, Nicholas P. Rhodes, Michael H. Gelb, Kersten K. Koelsch, M. Suter, Birgit A. Helm
Publicado 1995Artigo -
12
Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation por Siham Raboune, Jordyn Stuart, Emma Leishman, Sara M. Takacs, Brandon P. Rhodes, А. Баснет, Evan Jameyfield, Douglas McHugh, Theodore S. Widlanski, Heather B. Bradshaw
Publicado 2014Artigo -
13
-
14
Ras activation by SOS: Allosteric regulation by altered fluctuation dynamics por Lars Iversen, Hsiung‐Lin Tu, Wan‐Chen Lin, Sune M. Christensen, Steven M. Abel, Jeff Iwig, Hung‐Jen Wu, Jodi Gureasko, Christopher P. Rhodes, Rebecca S. Petit, Scott D. Hansen, Peter Thill, Cheng‐han Yu, Dimitrios Stamou, Arup K. Chakraborty, John Kuriyan, Jay T. Groves
Publicado 2014Artigo -
15
Selective RET kinase inhibition for patients with RET-altered cancers por Vivek Subbiah, Vamsidhar Velcheti, Brian B. Tuch, Kevin Ebata, Naifa L. Busaidy, Maria E. Cabanillas, Lori J. Wirth, Sarah J. Stock, Steven G. Smith, Veronique Lauriault, Stefani Corsi-Travali, Dahlia Henry, Mark E. Burkard, R. Hamor, Karyn Bouhana, Shannon L. Winski, Ross Wallace, Dylan P. Hartley, Susan P. Rhodes, Mamatha M. Reddy, Barbara J. Brandhuber, Steven D. Andrews, S. Michael Rothenberg, Alexander Drilon
Publicado 2018Artigo -
16
Identification of the Clinical Development Candidate <b>MRTX849</b>, a Covalent KRAS<sup>G12C</sup> Inhibitor for the Treatment of Cancer por Jay B. Fell, John P. Fischer, Brian R. Baer, James F. Blake, Karyn Bouhana, David M. Briere, Karin Brown, Laurence E. Burgess, Aaron C. Burns, Michael Burkard, Harrah Chiang, Mark J. Chicarelli, Adam W. Cook, John J. Gaudino, Jill Hallin, Lauren Hanson, Dylan P. Hartley, Erik J. Hicken, Gary P. Hingorani, Ronald J. Hinklin, Macedonio J. Mejia, Peter Olson, Jennifer Otten, Susan P. Rhodes, Martha E. Rodriguez, Pavel Y. Savechenkov, Darin Smith, Niranjan Sudhakar, Francis X. Sullivan, Tony P. Tang, Guy Vigers, Lance Wollenberg, James G. Christensen, Matthew A. Marx
Publicado 2020Artigo
Ferramentas de procura:
Materias Relacionadas
Biochemistry
Biology
Chemistry
Medicine
Gene
Enzyme
Internal medicine
Receptor
Biophysics
Cell
Cell biology
Genetics
In vitro
Organic chemistry
Antibody
Cancer
Cell membrane
Cell signaling
Immunology
Inflammation
Materials science
Membrane
Membrane protein
Microglia
Molecular biology
Nanotechnology
Pharmacology
Philosophy
RNA
RNA polymerase